In proliferation assays, a reduction in CHEK1 expression retarded CRC cell growth (Figure 5A) and concomitantly activated apoptotic signalling, as indicated by increased cleavage of PARP and Caspase 3 (Figure 5B). Here, CASP3 is linked to colorectal carcinoma.